Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
- PMID: 29381150
- DOI: 10.1038/leu.2017.348
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
Abstract
This corrects the article DOI: 10.1038/leu.2017.9.
Erratum for
-
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.Leukemia. 2017 Apr;31(4):829-836. doi: 10.1038/leu.2017.9. Epub 2017 Jan 11. Leukemia. 2017. PMID: 28074067
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
